Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by Breast Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Sarah Lawrence College
University of Washington
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT00590109
First received: December 26, 2007
Last updated: January 4, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)